The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 11,201–11,300 of 31,469
Fouret, G., Gaillet, S., Lecomte, J., Bonafos, B., Djohan, Y. F., Baréa, B., Badia, É., Coudray, C., & Feillet‐Coudray, C. (2018) · British Journal Of Nutrition · doi:10.1017/s0007114517003713 · Cited by 32
Pae, M., Baek, Y., Lee, S., & Wu, D. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.03.011 · Cited by 31
Rakshit, K., Qian, J., Gaonkar, K. S., Dhawan, S., Colwell, C. S., & Matveyenko, A. V. (2018) · Diabetes · doi:10.2337/db17-0850 · Cited by 31
Iwata, M., Hara, K., Kamura, Y., Honoki, H., Fujisaka, S., Ishiki, M., Usui, I., Yagi, K., Fukushima, Y., Takano, A., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192609 · Cited by 31
Thyroid-Stimulating Hormone Levels Are Positively Associated with Insulin Resistance
Zhu, P., Liu, X., & Mao, X. (2018) · Medical Science Monitor · doi:10.12659/msm.905774 · Cited by 32
Zou, J., Xia, Y., Xu, H., Fu, Y., Qian, Y., Li, X., Zhao, X., Zou, J., Meng, L., Liu, S., et al. (2018) · Metabolism · doi:10.1016/j.metabol.2017.11.021 · Cited by 32
Lee, S., Yim, Y.-S., Lee, Y., Lee, B., Kim, H.-S., Kim, K., Lee, Y.-W., & Kim, J. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.028 · Cited by 32
Bardagjy, A. S., Hu, Q., Giebler, K., Ford, A., & Steinberg, F. M. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.04.003 · Cited by 31
Gross, A. C., Kaizer, A. M., Ryder, J. R., Fox, C. K., Rudser, K. D., Dengel, D. R., & Kelly, A. S. (2018) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2018.03.059 · Cited by 32
Desmarais, F., Bergeron, K., Lacaille, M., Lemieux, I., Bergeron, J., Biron, S., Rassart, É., Joanisse, D. R., Mauriège, P., & Mounier, C. (2018) · Endocrine · doi:10.1007/s12020-018-1621-5 · Cited by 32
Yorifuji, T., Higuchi, S., Kawakita, R., Hosokawa, Y., Aoyama, T., Murakami, A., Kawae, Y., Hatake, K., Nagasaka, H., & Tamagawa, N. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12714 · Cited by 31
Bradley, D. P., Liu, J., Blaszczak, A. M., Wright, V. P., Jalilvand, A., NEEDLEMAN, B. J., Noria, S. F., Renton, D., & Hsueh, W. A. (2018) · Journal of Diabetes Research · doi:10.1155/2018/2464652 · Cited by 31
Poveda, N. E., Garcés, M. F., Darghan, A. E., Jaimes, S. A. B., Sánchez, E. P., Díaz-Cruz, L. A., Garzón-Olivares, C. D., Parra‐Pineda, M. O., Bautista‐Charry, A. A., Müller, E. Á., et al. (2018) · International Journal of Endocrinology · doi:10.1155/2018/8956404 · Cited by 31
Mônico‐Neto, M., Antunes, H. K. M., dos Santos, R. V. T., D’Almeida, V., de Souza, A. A. L., Bittencourt, L., & Tufik, S. B. (2018) · European Respiratory Journal · doi:10.1183/13993003.01972-2017 · Cited by 37
Safhi, M. M., Anwer, T., Khan, G., Siddiqui, R., Moni, S. S., & Alam, M. F. (2018) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2018.22.5.493 · Cited by 32
Simmons, D. S., Devlieger, R., Assche, A. V., Galjaard, S., Corcoy, R., Adelantado, J. M., Dunne, F., Desoyé, G., Kautzky‐Willer, A., Damm, P., et al. (2018) · Nutrients · doi:10.3390/nu10111568 · Cited by 31
Aslfalah, H., Jamilian, M., & Khosrowbeygi, A. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1519795 · Cited by 31
Expression of toll-like receptor 4 and its connection with type 2 diabetes mellitus
Taha, I. M., Allah, A. M. A., & Gayed, E. M. A. E. (2018) · Cellular and Molecular Biology · doi:10.14715/cmb/2018.64.13.4 · Cited by 31
Calza, L., Colangeli, V., Borderi, M., Coladonato, S., Tazza, B., Bon, I., Re, M. C., & Viale, P. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky507 · Cited by 31
Early age at menarche is associated with insulin resistance: a systemic review and meta-analysis
Zhang, Z., Hu, X., Yang, C., & Chen, X. (2018) · Postgraduate Medicine · doi:10.1080/00325481.2019.1559429 · Cited by 31
Cooksey, R., Wu, S. Y., Klesse, L. J., Oden, J. D., Bland, R. E., Hodges, J. C., Gargan, L., Vega, G. L., & Bowers, D. C. (2018) · Journal of Investigative Medicine · doi:10.1136/jim-2018-000911 · Cited by 32
Hart, R. J., Doherty, D. A., Mori, T. A., Adams, L. A., Huang, R. C., Minaee, N. S., Handelsman, D. J., McLachlan, R. I., Norman, R. J., Dickinson, J. E., et al. (2018) · Human Reproduction · doi:10.1093/humrep/dey371 · Cited by 30
Maxwell, D. W., Jajja, M. R., Tariq, M., Mahmooth, Z., Galindo, R. J., Sweeney, J. F., & Sarmiento, J. M. (2019) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2018.12.042 · Cited by 31
Khalaf, S. S., Hafez, M. M., Mehanna, E. T., Mesbah, N. M., & Abo–Elmatty, D. M. (2019) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01616-3 · Cited by 31
Chronic mercury at low doses impairs white adipose tissue plasticity
Rizzetti, D. A., Corrales, P., Piagette, J. T., Uranga, J. A., Medina‐Gómez, G., Peçanha, F. M., Vassallo, D. V., Miguel, M., & Wiggers, G. A. (2019) · Toxicology · doi:10.1016/j.tox.2019.02.013 · Cited by 31
High-intensity interval training reduces monocyte activation in obese adults
de Matos, M. A., Garcia, B. C. C., Vieira, D. V., de Oliveira, M. F. A., Costa, K. B., Aguiar, P. F., Magalhães, F. D. C., de Melo, G. E. B. A., Amorim, F. T., & Rocha‐Vieira, E. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.05.030 · Cited by 31
Li, T., Li, H., Li, W., Chen, S., Feng, T., Jiao, W., Wu, C., Dong, J., Li, Y., Li, S., et al. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.06.008 · Cited by 31
Nyangasa, M. A., Buck, C., Kelm, S., Sheikh, M. A., Brackmann, L. K., & Hebestreit, A. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025397 · Cited by 32
Bettini, S., Favaretto, F., Compagnin, C., Belligoli, A., Sanna, M., Fabris, R., Serra, R., Prà, C. D., Prevedello, L., D, M. F. M., et al. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00548 · Cited by 33
Harvie, M., Pegington, M., McMullan, D., Bundred, N. J., Livingstone, K., Campbell, A., Wolstenholme, J. L., Lovato, E., Campbell, H., Adams, J. E., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0522-6 · Cited by 34
Retnakaran, R. R., Chang, Y. R., Connelly, P. W., Hanley, A. J., Sermer, M., & Zinman, B. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313195 · Cited by 32
Behmanesh, N., Abedelahi, A., Charoudeh, H. N., & Alihemmati, A. (2019) · Journal of Turkish Society of Obstetric and Gynecology · doi:10.4274/tjod.galenos.2019.46244 · Cited by 32
Aroda, V. R., Capehorn, M., CHAYKIN, L. B., Frías, J. P., Lausvig, N. L., Macura, S., Lüdemann, J., Madsbad, S., Rosenstock, J., Tabak, Ö., et al. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13896 · Cited by 34
Ponce, O., Benassi, R., & Cesar, T. B. (2019) · Journal of Nutrition & Intermediary Metabolism · doi:10.1016/j.jnim.2019.100101 · Cited by 33
Diabetes development after distal pancreatectomy: results of a 10 year series
Tariq, M., Jajja, M. R., Maxwell, D. W., Galindo, R. J., Sweeney, J. F., & Sarmiento, J. M. (2019) · HPB · doi:10.1016/j.hpb.2019.10.2440 · Cited by 31
Tosi, F., Molin, F. D., Zamboni, F., Saggiorato, E., Salvagno, G. L., Fiers, T., Kaufman, J., Bonora, E., & Moghetti, P. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa095 · Cited by 31
Neuroanatomical changes in white and grey matter after sleeve gastrectomy
Michaud, A., Dadar, M., Pelletier, M., Zeighami, Y., García‐García, I., Iceta, S., Yau, Y. H. C., Nadeau, M., Marceau, S., Biertho, L. D., et al. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.116696 · Cited by 31
Moriyama, K. (2020) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2019.0123 · Cited by 31
Olaniyi, K. S., Amusa, O. A., Areola, E. D., & Olatunji, L. A. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220913847 · Cited by 33
Mansour, A., Mohajeri‐Tehrani, M. R., Karimi, S., Sanginabadi, M., Poustchi, H., Enayati, S., Asgarbeik, S., Nasrollahzadeh, J., & Hekmatdoost, A. (2019) · EXCLI journal · doi:10.17179/excli2019-2021 · Cited by 31
Metabolic Syndrome and Insulin Resistance in Schoolchildren From a Developing Country
Das, R. R., Mangaraj, M., Panigrahi, S. K., Satapathy, A. K., Mahapatro, S., & Ray, P. S. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.00031 · Cited by 30
Lee, K. (2020) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-020-01104-2 · Cited by 32
Trajectories of BMI Before Diagnosis of Type 2 Diabetes: The Rotterdam Study
Nano, J., Dhana, K., Asllanaj, E., Sijbrands, E. J. G., Ikram, M. A., Dehghan, A., Muka, T., & Franco, O. H. (2020) · Obesity · doi:10.1002/oby.22802 · Cited by 31
Georgoulis, M., Yiannakouris, N., Kechribari, I., Lamprou, K., Perraki, E., Vagiakis, E., & Kontogianni, M. D. (2020) · Nutrients · doi:10.3390/nu12061570 · Cited by 35
Boughanem, H., Cabrera-Mulero, A., Hernández‐Alonso, P., Clemente‐Postigo, M., Casanueva, F. F., Tinahones, F. J., Morcillo, S., Crujeiras, A. B., & Macías‐González, M. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00875-9 · Cited by 32
Han, Y., Kwon, E., & Choi, M. (2020) · Nutrients · doi:10.3390/nu12072113 · Cited by 33
Prevalence and Predictors of Insulin Resistance in Non-Obese Healthy Young Females in Qatar
Elrayess, M. A., Rizk, N. M., Fadel, A., & Kerkadi, A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17145088 · Cited by 31
Polak, A. M., Krentowska, A., Łebkowska, A., Buczyńska, A., Adamski, M., Adamska-Patruno, E., Fiedorczuk, J., Krętowski, A. J., Kowalska, I., & Adamska, A. (2020) · Nutrients · doi:10.3390/nu12092753 · Cited by 31
Plasma C-Peptide and Risk of Developing Type 2 Diabetes in the General Population
Sokooti, S., Kieneker, L. M., de Borst, M. H., Kobold, A. C. M., Kootstra‐Ros, J. E., Gloerich, J., van Gool, A. J., Heerspink, H. J. L., Gansevoort, R. T., Dullaart, R. P. F., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9093001 · Cited by 33
Marzuca-Nassr, G. N., Artigas-Arias, M., Olea, M. A., SanMartín-Calísto, Y., Huard, N., Durán-Vejar, F., Beltrán-Fuentes, F., Muñoz-Fernández, A., Alegría-Molina, A., SAPUNAR, J., et al. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111096 · Cited by 31
Insights from the clinical phenotype of subjects with Laron syndrome in Ecuador
Guevara‐Aguirre, J., Bautista, C., Torres, C. D., Peña, G., Guevara, C., Palacios, C. S., Guevara, A., & Gavilanes, A. W. D. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09602-4 · Cited by 31
DiBella, M., Thomas, M. S., Alyousef, H., Millar, C. L., Blesso, C. N., Malysheva, O., Caudill, M. A., & Fernández, M. L. (2020) · Nutrients · doi:10.3390/nu12103120 · Cited by 31
Bariatric Surgery Normalizes Protein Glycoxidation and Nitrosative Stress in Morbidly Obese Patients
Choromańska, B., Myśliwiec, P., Łuba, M., Wojskowicz, P., Myśliwiec, H., Choromańska, K., Dadan, J., Żendzian‐Piotrowska, M., Zalewska, A., & Maciejczyk, M. (2020) · Antioxidants · doi:10.3390/antiox9111087 · Cited by 30
Bannitz, R. F., Welendorf, C. R., Coelho, P. O., Salgado, W., Nonino, C. B., Beraldo, R. A., & Foss‐Freitas, M. C. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00623-w · Cited by 32
Lee, K. W., & Shin, D. (2020) · Nutrition Journal · doi:10.1186/s12937-020-00653-6 · Cited by 32
Krentowska, A., Łebkowska, A., Jacewicz‐Święcka, M., Hryniewicka, J., Leśniewska, M., Adamska, A., & Kowalska, I. (2021) · Endocrine · doi:10.1007/s12020-020-02596-8 · Cited by 32
Tang, L., Li, P., Zhou, H., & Li, L. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3441 · Cited by 31
Role of inflammatory markers in polycystic ovaries syndrome: In relation to insulin resistance
Alissa, E. M., Algarni, S. A., Khaffji, A. J., & Mansouri, N. M. A. (2021) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14684 · Cited by 31
Hou, J., Tu, R., Dong, Y., Liu, X., Dong, X., Li, R., Pan, M., Yin, S., Hu, K., Mao, Z., et al. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.145834 · Cited by 31
Sex-Dependent Association of Vitamin D With Insulin Resistance in Humans
Chen, X., Chu, C., Doebis, C., von Baehr, V., & Hocher, B. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab213 · Cited by 35
Prasatthong, P., Meephat, S., Rattanakanokchai, S., Khamseekaew, J., Bunbupha, S., Prachaney, P., Maneesai, P., & Pakdeechote, P. (2021) · Antioxidants · doi:10.3390/antiox10050769 · Cited by 33
Growth differentiation factor 15 increases in both cerebrospinal fluid and serum during pregnancy
Andersson-Hall, U. K., Svedin, P., Mallard, C. E., Blennow, K., Zetterberg, H., & Holmäng, A. B. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248980 · Cited by 32
Creld2 function during unfolded protein response is essential for liver metabolism homeostasis
Kern, P., Balzer, N. R., Blank-Stein, N., Cygon, C., Wunderling, K., Bender, F., Frolov, A., Sowa, J., Bonaguro, L., Ulas, T., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202002713rr · Cited by 32
O balon intragastric balloon in the treatment of paediatric obesity: a pilot study
Nobili, V., Corte, C. D., Liccardo, D., Mosca, A., Caccamo, R., Morino, G. S., Alterio, A., & PEPPO, F. D. (2014) · Pediatric Obesity · doi:10.1111/ijpo.268 · Cited by 31
Guo, X., Wang, C., Yang, T., Ma, W., Zhai, J., Zhao, T., Xu, T., Li, ., He, L., Sinclair, A. J., et al. (2022) · European Journal of Nutrition · doi:10.1007/s00394-021-02772-0 · Cited by 32
Plasma apolipoprotein concentrations and incident diabetes in subjects with prediabetes
Croyal, M., Wargny, M., Chemello, K., Chevalier, C., Blanchard, V., Bigot‐Corbel, E., Lambert, G. C., May, C. L., Hadjadj, S., & Cariou, B. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01452-5 · Cited by 32
El-Kady, R. R., Ali, A. K., Wakeel, L. M. E., Sabri, N. A., & Shawki, M. A. (2022) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223221077958 · Cited by 32
Zhou, Y., Yang, G., Chen, Q., Chen, J., Qian, Y., Yuan, L., Mao, T., Xu, Y. J., Li, X., Zhen, S., et al. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-00984-x · Cited by 32
Washed microbiota transplantation improves patients with high blood glucose in South China
Wu, L., Li, M.-Q., Xie, Y.-T., Zhang, Q., Lu, X., Liu, T., Lin, W.-Y., Xu, J., Wu, Q., & He, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.985636 · Cited by 31
Primo, D., Izaola, O., & de Luis, D. A. (2022) · Annals of Nutrition and Metabolism · doi:10.1159/000526988 · Cited by 31
Reyes‐López, R., Pérez-Luque, E. L., & Malacara, J. M. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2538 · Cited by 31
Zhu, Y., Zhang, M., Hou, X., Lu, J., Peng, L.-P., Gu, H., Wang, C., & Jia, W. (2011) · PubMed · doi:10.3967/0895-3988.2011.05.004 · Cited by 31
The effects of oral vitamin D on insulin resistance in pre-diabetic patients.
Hoseini, S. A., Aminorroaya, A., Iraj, B., & Amini, M. (2013) · Europe PMC (PubMed Central) · Cited by 31
Obesity-related differences in neuromuscular fatigue in adolescent girls
García-Vicencio, S., Martin, V., Kluka, V., et al. (2015) · European Journal of Applied Physiology · doi:10.1007/s00421-015-3222-9 · Cited by 31
Jung, J. G., Kim, J. S., & Oh, M. K. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01256.x · Cited by 31
Mendham, A. E., Duffield, R., Coutts, A. J., Marino, F. E., Boyko, A., & Bishop, D. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127548 · Cited by 31
Moța, E., Popa, S. G., Moța, M., et al. (2015) · International Urology and Nephrology · doi:10.1007/s11255-015-1109-7 · Cited by 31
Şahin, F. K., Şahin, S. B., Ural, Ü. M., Cüre, M. C., Şentürk, Ş., Tekın, Y. B., Balık, G., Cüre, E., Yuce, S., & Kırbaş, A. (2015) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2015.432 · Cited by 31
Huda, M. S. B., Mani, H., Dovey, T. M., Halford, J. C. G., Boyland, E. J., Daousi, C., Wilding, J. P. H., & Pinkney, J. H. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03865.x · Cited by 31
Association between whole blood mercury and glucose intolerance among adult Inuit in Greenland
Jeppesen, C., Valéra, B., Nielsen, N. O., Bjerregaard, P., & Jørgensen, M. E. (2015) · Environmental Research · doi:10.1016/j.envres.2015.10.013 · Cited by 33
Hallikainen, M., Toppinen, L., Mykkänen, H. M., Ågren, J. J., Laaksonen, D. E., Miettinen, T. A., NISKANEN, L. K., Poutanen, K. S., & Gylling, H. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.6.1385 · Cited by 30
Gopalsamy, R. G., Vanlalhruaia, P., Stalin, A., Irudayaraj, S. S., Savarimuthu Ignacimuthu, S. J., & Paulraj, M. G. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.02.001 · Cited by 31
Impact of postprandial and fasting glucose concentrations on HbA1c in patients with type 2 diabetes
Schernthaner, G., Guerci, B., Gallwitz, B., Rose, L., Nicolay, C., Kraus, P., & KAZDA, C. M. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.04.004 · Cited by 31
Glucose tolerance and insulin resistance in Indian children: relationship to infant feeding pattern
Veena, S. R., Krishnaveni, G. V., Wills, A. K., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2254-x · Cited by 31
Hussein, M. A. (2011) · Free Radicals and Antioxidants · doi:10.5530/ax.2011.1.9 · Cited by 31
Shimizu, H., Eldar, S. M., Heneghan, H., Schauer, P. R., Kirwan, J. P., & Brethauer, S. A. (2013) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2013.01.021 · Cited by 31
de Oliveira, L. P. M., de Jesús, R. P., Boulhosa, R. S. S. B., et al. (2012) · Clinics · doi:10.6061/clinics/2012(03)03 · Cited by 31
Idorn, T., Knop, F. K., Jørgensen, M. B., Holst, J. J., Hornum, M., & Feldt‐Rasmussen, B. (2013) · Kidney International · doi:10.1038/ki.2012.460 · Cited by 32
Gómez, J. M., Vila-Coll, R., Catalina, P. F., Soler, J., Badimón, L., & Sahún, M. J. S. (2008) · Glycoconjugate Journal · doi:10.1007/s10719-008-9118-8 · Cited by 31
Trento, M., Passera, P., Miselli, V., Bajardi, M., Borgo, E., Tomelini, M., Tomalino, M., Cavallo, F., & Porta, M. (2006) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70250-1 · Cited by 32
Wang, Y., Wang, P., Qin, L., Ganmaa, D., Kaneko, T., Xu, J., Murata, S., Katoh, R., & Sato, A. (2003) · Endocrine · doi:10.1385/endo:22:2:85 · Cited by 31
Fenkçi, S. M., Rota, S., Sabir, N., Sermez, Y., Güçlü, A., & Akdağ, B. (2006) · Journal of Investigative Medicine · doi:10.2310/6650.2006.06010 · Cited by 31
The association of insulin resistance with serum osteoprotegerin in obese adolescents
Suliburska, J., Bogdański, P., Gajewska, E., Kalmus, G., Sobieska, M., & Samborski, W. (2013) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-013-0261-8 · Cited by 31
Chung, S. J., Lee, Y. A., Hong, H., Kang, M. J., Kwon, H. J., Shin, C. H., & Yang, S. W. (2013) · Public Health Nutrition · doi:10.1017/s1368980013002334 · Cited by 30
Rhee, E., Kim, Y., Lee, W., Jung, C., Sung, K., Ryu, S., Oh, K.-W., & Kim, S.-W. (2006) · Metabolism · doi:10.1016/j.metabol.2005.08.010 · Cited by 31
Effects of Qigong on Glucose Control in Type 2 Diabetes
Sun, G. C., Lovejoy, J. C., Gillham, S., Putiri, A., Sasagawa, M., & Bradley, R. D. (2009) · Diabetes Care · doi:10.2337/dc09-1543 · Cited by 31
Näf, S., Escoté, X., Ballesteros, M., Yañez, R. E., Simón‐Muela, I., Gil, P., Albaigés, G., Vendrell, J. J., & Megía, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092175 · Cited by 31
Soesanto, Y., Luo, B., Parker, G. J., Jones, D., Cooksey, R. C., & McClain, D. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.249508 · Cited by 30
Two‐Dimensional Strain and Twist by Vector Velocity Imaging in Adolescents With Severe Obesity
Obert, P., Gueugnon, C., Nottin, S., Vinet, A., Gayrard, S., Rupp, T., Dumoulin, G., Tordi, N., & Mougin, F. (2012) · Obesity · doi:10.1038/oby.2012.111 · Cited by 30
Krikken, J. A., Gansevoort, R. T., & Dullaart, R. P. F. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m005348 · Cited by 31
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
